Evaluation of Agnikarma in management of spasticity in children with spastic cerebral palsy - a randomised controlled clinical trial - Nil

KLE Ayurveda Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•Children of either sex in age group between 5 years-16 years.
•Children fulfilling the diagnostic criteria.
•Children who have not received any form of modern intervention for spasticity at least for last 1 month.

•Children with non-spastic Cerebral Palsy will be excluded.
•Children with any known major congenital anomalies like Congenital Heart Disease (CHD) etc. will be excluded.
•Children with other disease status like Acute infections, severe systemic illness and children with any progressive neurologic anomalies will be excluded.
•Children with any other diseases or any other drugs that may interfere with the study outcome will be excluded.
•Children under gone any surgery intervention for spasticity will be excluded.
•Children having local inflammation or skin lesion on the site of spasticity will be excluded.

发起方

KLE Ayurveda Hospital